Sign in and upgrade to a paid plan to export corporate actions as CSV.

Arvee Laboratories (India) Limited

Chemicals

NSE: ARVEE
₹225.16
▼ -7.69 (-3.30%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
87/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
46.1
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-3 Cr
as of March 31, 2026
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 2 met
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

1 of 1 met
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

2 of 4 met
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-3.3%
Low 222.2000 · High 235.7900
1W return
-7.0%
Low 210.2000 · High 249.0000
1M return
33.6%
Low 162.0000 · High 255.0000
52W return
41.7%
Low 129.1100 · High 290.7800
Lifetime High ₹306.7000 (April 10, 2024)
Lifetime Low ₹37.6000 (June 8, 2020)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish1
5D
225.8
10D
217.3
20D
203.5
50D
185.3
100D
176.8
200D
171.1

Delivery and volume

Day avg. delivery
44.9%
Week avg. delivery
40.4%
Month avg. delivery
30.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

227.72
Pivot
First resistance233.23
Second resistance241.31
Third resistance246.82
First support219.64
Second support214.13
Third support206.05
Day RSI60.6
Day MFI85.3
Day MACD16.01
Day MACD signal12.47

Beta

1M0.12
3M-0.20
1Y0.93
3Y0.43

Price change analysis

↑ 33.6%
Over 1 Month
LowHigh
162.00255.00
↑ 38.5%
Over 3 Months
LowHigh
147.15255.00
↑ 56.4%
Over 6 Months
LowHigh
130.40255.00
↑ 41.7%
Over 1 Year
LowHigh
129.11290.78
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹17 Cr
Net profit (June 30, 2026)
₹2 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter73.50%

Largest holders

NameCategoryShares %Shares
SHALIN SUDHAKARBHAI PATELPromoter36.6800%4042000
MITABEN BHARATBHAI CHOKSHIPromoter24.5700%2708000
KAVITA SHALIN CHOKSHIPromoter12.1600%1340000
GITABEN DINEHSBHAI PATELPublic9.9800%1100000
DEVAL PRANAV PATELPublic5.1900%572000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 73.50% in Jun 2026 qtr

Historical fii holding

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 8 insider trades, 4 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
28 Dec 2022 SAUMIL BHARATBHAI CHOKSHI Promoter group Sell 0 ₹0
28 Dec 2022 MITABEN BHARATBHAI CHOKSHI Promoter group Buy 0 ₹0
15 Sep 2022 BHARAT RASIKLAL CHOKSHI Promoter group Sell 0 ₹0
15 Sep 2022 SHALIN BHARATBHAI CHOKSHI Promoter Sell 0 ₹0
15 Sep 2022 Saumil Bharat Chokshi Promoter group Sell 0 ₹0
15 Sep 2022 MITABEN BHARAT CHOKSHI Promoter group Buy 0 ₹0
15 Sep 2022 KAVITA SHALIN CHOKSHI Promoter group Buy 0 ₹0
14 Feb 2022 SHALIN SUDHAKARBHAI PATEL Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
8 Mar 2018 SHAH MISHA ASHISH Bulk Sell 32,000 50.4600 NSE
8 Mar 2018 PRAMOD VASWANI HUF Bulk Sell 28,000 62.9800 NSE
8 Mar 2018 PRAMOD VASWANI HUF Bulk Buy 28,000 49.1000 NSE
5 Mar 2018 SHAH MISHA ASHISH Bulk Buy 32,000 59.6300 NSE
5 Mar 2018 HUF SHAH ASHISH NAVNITLAL Bulk Sell 44,000 57.8300 NSE
28 Feb 2018 PATEL GITABEN DINEHSBHAI Bulk Buy 96,000 56.1400 NSE
28 Feb 2018 HUF SHAH ASHISH NAVNITLAL Bulk Sell 90,000 56.1500 NSE
27 Feb 2018 PATEL PRANAV Bulk Buy 92,000 60.1600 NSE
27 Feb 2018 PATEL GITABEN DINEHSBHAI Bulk Buy 160,000 60.1300 NSE
27 Feb 2018 HUF SHAH ASHISH NAVNITLAL Bulk Sell 232,000 60.1700 NSE

All bulk and block deals →

Corporate Actions

Full history (4 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
20 Sep 2024OTHERAnnual General Meeting
15 Sep 2023OTHERAnnual General Meeting
28 Jul 2022OTHERAnnual General Meeting
16 Sep 2021OTHER Annual General Meeting

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
7 Aug 2026 Financial Results/Other business matters Yes
19 May 2026 Financial Results/Other business matters Yes
18 May 2026 Financial Results/Other business matters Yes
13 Feb 2026 Financial Results/Other business matters Yes
14 Nov 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 260 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Shareholders meeting Arvee Laboratories (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2025. Further, the company has informed the Exchange regarding voting results.
29 Sep 2026 Shareholders meeting Proceedings of Annual General Meeting held today that is 29th September, 2026
15 Sep 2026 Trading Window Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
9 Sep 2026 Cessation Arvee Laboratories (India) Limited has informed the Exchange regarding Cessation of Mrs Raina Singh as Company Secretary & Compliance Officer of the company w.e.f. September 09, 2026.
7 Aug 2026 Outcome of Board Meeting Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
4 Aug 2026 Corrigendum Arvee Laboratories (India) Limited has informed the Exchange regarding Corrigendum to Other
27 Jun 2026 Trading Window Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
15 Jun 2026 Disclosure under SEBI Takeover Regulations Shalin Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
19 May 2026 Outcome of Board Meeting Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
15 Apr 2026 Price movement Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Arvee Laboratories (India) Limited has submitted their response.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Arvee Laboratories (India) Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.